Alternative RNA splicing in cancer: what about adult T-cell leukemia? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Frontiers in Immunology Année : 2022

Alternative RNA splicing in cancer: what about adult T-cell leukemia?

Résumé

Eukaryotic cells employ a broad range of mechanisms to regulate gene expression. Among others, mRNA alternative splicing is a key process. It consists of introns removal from an immature mRNA (pre-mRNA) via a transesterification reaction to create a mature mRNA molecule. Large-scale genomic studies have shown that in the human genome, almost 95% of protein-encoding genes go through alternative splicing and produce transcripts with different exons combinations (and sometimes retained introns), thus increasing the proteome diversity. Considering the importance of RNA regulation in cellular proliferation, survival, and differentiation, alterations in the alternative splicing pathway have been linked to several human cancers, including adult T-cell leukemia/lymphoma (ATL). ATL is an aggressive and fatal malignancy caused by the Human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 genome encodes for two oncoproteins: Tax and HBZ, both playing significant roles in the transformation of infected cells and ATL onset. Here, we review current knowledge on alternative splicing and its link to cancers and reflect on how dysregulation of this pathway could participate in HTLV-1-induced cellular transformation and adult T-cell leukemia/lymphoma development.
Fichier principal
Vignette du fichier
fimmu-13-959382.pdf (1.31 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04277550 , version 1 (30-05-2024)

Identifiants

Citer

Julie Tram, Jean-Michel Mesnard, Jean-Marie Peloponese. Alternative RNA splicing in cancer: what about adult T-cell leukemia?. Frontiers in Immunology, 2022, 13, pp.959382. ⟨10.3389/fimmu.2022.959382⟩. ⟨hal-04277550⟩
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More